Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...

Travere’s stock price climbed by 14% following the announcement that it will seek an FDA label expansion for Filspari.

Blockchain is poised to redefine pharmaceutical validation, offering unparalleled improvements in data integrity, compliance, ...

Foreign participants at the 16th Asia Pharma Expo foresee a bright future for Bangladesh’s pharmaceutical industry, given its ...

Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the ...

The finest minds from the pharma firmament will also be sharing insights on the changing landscape and on the new imperatives ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

We are now in crisis again because of Donald Trump’s executive order freezing aid. Surely local drug manufacture now needs to be implemented without any further delay?

KAMPALA - Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic ...

Johnson & Johnson — leaders in healthcare innovation, where treatments are smarter and less invasive, and solutions are ...